Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'INTERFERON ALPHA-2A' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 199 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Sondak, VK
      Adjuvant therapy for melanoma

      CANCER JOURNAL
    2. Lao, YH
      Endogenous angiogenesis inhibitors and their therapeutic implications

      INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
    3. Altucci, L; Rossin, A; Raffelsberger, W; Reitmair, A; Chomienne, C; Gronemeyer, H
      Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrineaction of tumor-selective death ligand TRAIL

      NATURE MEDICINE
    4. Nichols, JC; Ince, A; Akduman, L; Mann, ES
      Interferon-alpha 2a treatment of neuro-Behcet disease

      JOURNAL OF NEURO-OPHTHALMOLOGY
    5. Godley, PA; Taylor, M
      Renal cell carcinoma

      CURRENT OPINION IN ONCOLOGY
    6. Lafuma, A; Dreno, B; Delaunay, M; Emery, C; Fagnani, F; Hieke, K; Bonerandi, JJ; Grob, JJ
      Economic analysis of adjuvant therapy with interferon alpha-2a in stage IImalignant melanoma

      EUROPEAN JOURNAL OF CANCER
    7. Metintas, M; Metintas, S; Ucgun, I; Gibbs, AR; Harmanci, E; Alatas, F; Erginel, S; Tel, N; Pasaoglu, O
      Prognostic factors in diffuse malignant pleural mesothelioma: effects of pretreatment clinical and laboratory characteristics

      RESPIRATORY MEDICINE
    8. Wu, HL; Ramachandran, C; Bielinska, AU; Kingzett, K; Sun, R; Weiner, ND; Roessler, BJ
      Topical transfection using plasmid DNA in a water-in-oil nanoemulsion

      INTERNATIONAL JOURNAL OF PHARMACEUTICS
    9. Grem, JL; Quinn, M; Ismail, AS; Takimoto, CH; Lush, R; Liewehr, DJ; Steinberg, SM; Balis, FM; Chen, AP; Monahan, BP; Harold, N; Corse, W; Pang, J; Murphy, RF; Allegra, CJ; Hamilton, JM
      Pharmacokinetics and pharmacodynamic effects of 5-fluorouracil given as a one-hour intravenous infusion

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    10. Sabatelli, M; Madia, F; Mignogna, T; Lippi, G; Quaranta, L; Tonali, P
      Pure motor chronic inflammatory demyelinating polyneuropathy

      JOURNAL OF NEUROLOGY
    11. Eggermont, AMM
      Frontiers in adjuvant therapy in stage II-III melanoma

      TUMORI
    12. Hadziyannis, AS; Papaioannou, C; Spanou, F; Manesis, EK; Hadziyannis, SJ
      Induction interferon therapy in nave patients with chronic hepatitis C: increased end-of-treatment virological responses but absence of long-term benefit

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    13. Vogelzang, NJ; Aklilu, M; Stadler, WM; Dumas, MC; Mikulski, SM
      A phase II trial of weekly intravenous ranpirnase (Onconase (R)), a novel ribonuclease in patients with metastatic kidney cancer

      INVESTIGATIONAL NEW DRUGS
    14. Saperstein, DS; Katz, JS; Amato, AA; Barohn, RJ
      Clinical spectrum of chronic acquired demyelinating polyneuropathies

      MUSCLE & NERVE
    15. Tannock, IF
      Removing the primary tumor after the cancer has spread

      NEW ENGLAND JOURNAL OF MEDICINE
    16. Madrona, AP; Escribano, JM; Ruiz, FN; Barba, EM; Jordana, MC; Gonzalez, JMR; Pedreno, PS; Fernandez, JLN; Iniesta, JF; Lopez, JB; Paricio, PP
      Sentinel node biopsy in melanoma using preoperative lymphoscintigraphy andintraoperative handheld gamma probe

      MEDICINA CLINICA
    17. Menetrier-Caux, C; Thomachot, MC; Alberti, L; Montmain, G; Blay, JY
      IL-4 prevents the blockade of dendritic cell differentiation induced by tumor cells

      CANCER RESEARCH
    18. Hall, GW
      Kasabach-Merritt syndrome: Pathogenesis and management

      BRITISH JOURNAL OF HAEMATOLOGY
    19. Blaheta, HJ; Paul, T; Sotlar, K; Maczey, E; Schittek, B; Paul, A; Moehrle, M; Breuninger, H; Bueltmann, B; Rassner, G; Garbe, C
      Detection of melanoma cells in sentinel lymph nodes, bone marrow and peripheral blood by a reverse transcription-polymerase chain reaction assay in patients with primary cutaneous melanoma: association with Breslow's tumour thickness

      BRITISH JOURNAL OF DERMATOLOGY
    20. Brownbridge, GG; Gold, J; Edward, M; MacKie, RM
      Evaluation of the use of tyrosinase-specific and melanA/MART-1-specific reverse transcriptase-coupled-polymerase chain reaction to detect melanoma cells in peripheral blood samples from 299 patients with malignant melanoma

      BRITISH JOURNAL OF DERMATOLOGY
    21. Yu, Y; Varughese, J; Brown, LF; Mulliken, JB; Bischoff, J
      Increased Tie2 expression, enhanced response to angiopoietin-1, and dysregulated angiopoietin-2 expression in hemangioma-derived endothelial cells

      AMERICAN JOURNAL OF PATHOLOGY
    22. Hauschild, A; Lischner, S; Christophers, E
      Surgical and systemic adjuvant treatment of head and neck primary melanoma.

      LARYNGO-RHINO-OTOLOGIE
    23. Royce, ME; Hoff, PM; Pazdur, R
      Progress in colorectal cancer chemotherapy - How far have we come, how farto go?

      DRUGS & AGING
    24. Bajetta, E; Bichisao, E; Artale, S; Celio, L; Ferrari, L; Di Bartolomeo, M; Zilembo, N; Stani, SC; Buzzoni, R
      New clinical trials for the treatment of neuroendocrine tumors

      QUARTERLY JOURNAL OF NUCLEAR MEDICINE
    25. Paller, AS
      Responses to anti-angiogenic therapies

      JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS
    26. Wu, K; Kim, HT; Rodriquez, JL; Munoz-Medellin, D; Mohsin, SK; Hilsenbeck, SG; Lamph, WW; Gottardis, MM; Shirley, MA; Kuhn, JG; Green, JE; Brown, PH
      9-cis-Retinoic acid suppresses mammary tumorigenesis in C3(1)-simian virus40 T antigen-transgenic mice

      CLINICAL CANCER RESEARCH
    27. Lee, ML; Tomsu, K; Von Eschen, KB
      Duration of survival for disseminated malignant melanoma: results of a meta-analysis

      MELANOMA RESEARCH
    28. Schoffski, P; Ganser, A; Pascheberg, U; Busche, G; Gaede, B; Hertenstein, B
      Complete haematological and cytogenetic response to interferon alpha-2a ofa myeloproliferative disorder with eosinophilia associated with a unique t(4;7) aberration

      ANNALS OF HEMATOLOGY
    29. Yao, GB; Fu, XX; Tian, GS; Xu, DZ; Hao, LJ; Huangfu, YS; Su, CX
      A multicenter, randomized, controlled trial of interferon alfacon-1 compared with alpha-2a-interferon in Chinese patients with chronic hepatitis C virus infection

      JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
    30. Motzer, RJ; Mazumdar, M; Bacik, J; Russo, P; Berg, WJ; Metz, EM
      Effect of cytokine therapy on survival for patients with advanced renal cell carcinoma

      JOURNAL OF CLINICAL ONCOLOGY
    31. Vasey, PA
      Immunotherapy for renal carcinoma: theoretical basis and current standard of care

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    32. Koshy, A; Marcellin, P; Martinot, M; Madda, JP
      Improved response to ribavirin interferon combination compared with interferon alone in patients with type 4 chronic hepatitis C without cirrhosis

      LIVER
    33. Amato, RJ
      Chemotherapy for renal cell carcinoma

      SEMINARS IN ONCOLOGY
    34. Coldiron, BM
      Sentinel node biopsy: who needs it?

      INTERNATIONAL JOURNAL OF DERMATOLOGY
    35. Blay, JY; Thomachot, MC; Alberti, L; Bachelot, T; Voorzanger-Rousselot, N; Puisieux, I; Odin, L; Menetrier-Caux, C
      Immunotherapy of cancers - New approaches

      BULLETIN DU CANCER
    36. Hauschild, A; Volkenandt, M; Garbe, C
      Adjuvant drug treatment of malignant melanoma

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    37. Piattelli, A; Fioroni, M; Santinelli, A; Rubini, C
      bcl-2 expression and apoptotic bodies in 13-cis-retinoic acid (isotretinoin)-topically treated oral leukoplakia: a pilot study

      ORAL ONCOLOGY
    38. Ravandi, F; Rytting, ME; Osmon, C; Braud, EL; Roach, RW; Edwards, K; Winn, R; Abbruzzese, JL; Pazdur, R
      Phase II trial of 5-fluorouracil, folinic acid and recombinant alpha-2a-interferon in patients with advanced colorectal cancer

      ANTI-CANCER DRUGS
    39. Zuetenhorst, H; Taal, BG; Boot, H; Olmos, RV; Hoefnagel, G
      Long-term palliation in metastatic carcinoid tumours with various applications of meta-iodobenzylguanidin (MIBC): pharmacological MIBG, I-131-labelled MIBG and the combination

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    40. Nakashima, T; Masuda, M; Matsui, K; Inokuchi, A; Kuraoka, A; Komiyama, S
      Induction of apoptosis in maxillary sinus cancer cells by 5-fluorouracil, vitamin A and radiation (FAR) therapy

      EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
    41. Kornek, G; Reiner, A; Sagaster, P; Stierer, M; Mayer, A; Ludwig, H
      Effect of interferon alpha-2a on hormone receptor status in patients with advanced breast cancer

      CANCER INVESTIGATION
    42. Mross, K; Scheulen, ME; Manegold, C; Westerhausen, M; Edler, L; Becher, R
      Phase II study with interferon alpha-2a and 13-cis-retinoic acid in patients with metastatic renal cell carcinoma - A trial of the phase II study group of the Association for Medical Oncology of the German Cancer Society

      ONKOLOGIE
    43. Parthasarathy, R; Gilbert, B; Mehta, K
      Aerosol delivery of liposomal all-trans-retinoic acid to the lungs

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    44. Damle, S; Beitler, JJ; Haynes, H; Camacho, M; Wolf, E; Wadler, S
      Phase I-II study of 5-fluorouracil, recombinant interferon alpha 2a, and cisplatin in combination with external beam radiation therapy followed by surgery in patients with locally advanced carcinoma of the esophagus

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    45. Gurer, US; Palanduz, S; Cevikbas, A; Derici, K; Johansson, C; Ozturk, S
      Effect of cefodizime, ofloxacin, ciprofloxacin and interferon alpha-2a, alone and in combination, on phagocytic and candidacidal functions of leucocytes from patients with chronic renal failure

      MEDICAL SCIENCE RESEARCH
    46. Ychou, M; Duffour, J; Pinguet, F; Kramar, A; Joulia, JM; Topart, D; Bressolle, F
      Individual 5FU-dose adaptation schedule using bimonthly pharmacokinetically modulated LV5FU2 regimen: A feasibility study in patients with advanced colorectal cancer

      ANTICANCER RESEARCH
    47. Wollina, U; Hahnfeld, S; Kosmehl, H
      Primary cutaneous marginal center lymphoma - complete remission induced byinterferon alpha 2a

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    48. DiPaola, RS
      Approaches to the treatment of patients with hormone-sensitive prostate cancer

      SEMINARS IN ONCOLOGY
    49. DiPaola, RS; Aisner, J
      Overcoming bcl-2- and p53-mediated resistance in prostate cancer

      SEMINARS IN ONCOLOGY
    50. Bajetta, E; Ferrari, L; Martinetti, A; Celio, L; Procopio, G; Artale, S; Zilembo, N; Di Bartolomeo, M; Seregni, E; Bombardieri, E
      Chromogranin A, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumors

      CANCER
    51. Dorval, T; Negrier, S; Chevreau, C; Avril, MF; Baume, D; Cupissol, D; Oskam, R; de Peuter, R; Vinke, J; Herrera, L; Escudier, B
      Randomized trial of treatment with cisplatin and interleukin-2 either alone or in combination with interferon-alpha-2a in patients with metastatic melanoma

      CANCER
    52. Hersey, P
      Advances in management of melanoma

      AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE
    53. Krogsgaard, K
      The long-term effect of treatment with interferon-alpha 2a in chronic hepatitis B

      JOURNAL OF VIRAL HEPATITIS
    54. RECCHIA F; FRATI L; REA S; TORCHIO P; SICA G
      MINIMAL RESIDUAL DISEASE IN METASTATIC BREAST-CANCER - TREATMENT WITHIFN-BETA, RETINOIDS, AND TAMOXIFEN

      Journal of interferon & cytokine research
    55. NASSIM M; ROUINI MR; CRIPPS MC; SHIRAZI FH; VEERASINGHAN S; MOLEPO JM; OBROCEA M; REDMOND D; BATES S; FRY D; STEWART DJ; GOEL R
      EFFECTS OF PALA ON THE PHARMACOKINETICS OF 5-FLUOROURACIL

      Oncology Reports
    56. PEREZ E; BARNADAS MA; GARCIAPATOS V; PEDRO C; CURELL R; SANDER CA; KIND P; DEMORAGAS JM; ALOMAR A
      KAPOSIS-SARCOMA IN A PATIENT WITH ERYTHROBLASTOPENIA AND THYMOMA - REACTIVATION AFTER TOPICAL CORTICOSTEROIDS

      Dermatology
    57. CAMPOVOEGELI A; ESTRACH T; MARTI RM; COROMINAS N; TUSET M; MASCARO JM
      ACROCYANOSIS INDUCED BY INTERFERON ALPHA(2A)

      Dermatology
    58. KIM J; ZHI JG; SATOH H; KOSSTWARDY SG; PASSE SM; PATEL IH; PAZDUR R
      PHARMACOKINETICS OF RECOMBINANT HUMAN INTERFERON-ALPHA-2A COMBINED WITH 5-FLUOROURACIL IN PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA

      Anti-cancer drugs
    59. JOZAN S; COURTADE M; MATHIEUBOUE A; LOCHON I; BUGAT R
      CYTOTOXIC EFFECT OF INTERFERON-ALPHA-2A IN COMBINATION WITH ALL-TRANS-RETINOIC ACID OR CISPLATIN IN HUMAN OVARIAN-CARCINOMA CELL-LINES

      Anti-cancer drugs
    60. Wright, SE; Hutcheson, DP; Cummins, JM
      Low dose oral interferon alpha 2a in HIV-1 seropositive patients: A double-blind, placebo-controlled trial

      BIOTHERAPY
    61. Lanvers, C; Hempel, G; Blaschke, G; Boos, J
      Chemically induced isomerization and differential uptake modulate retinoicacid disposition in HL-60 cells

      FASEB JOURNAL
    62. PARK TK; LEE JP; KIM SN; CHOI SM; KUDELKA AP; KAVANAGH JJ
      INTERFERON-ALPHA-2A, 13-CIS-RETINOIC ACID AND RADIOTHERAPY FOR LOCALLY ADVANCED-CARCINOMA OF THE CERVIX - A PILOT-STUDY

      European journal of gynaecological oncology
    63. RYU S; KIM OB; KIM SH; HE SQ; KIM JH
      IN-VITRO RADIOSENSITIZATION OF HUMAN CERVICAL-CARCINOMA CELLS BY COMBINED USE OF 13-CIS-RETINOIC ACID AND INTERFERON-ALPHA-2A

      International journal of radiation oncology, biology, physics
    64. Parthasarathy, R; Mehta, K
      Altered metabolism of all-trans-retinoic acid in liposome-encapsulated form

      CANCER LETTERS
    65. TRYFONAS GI; TSIKOPOULOS G; LIASIDOU E; GAVOPOULOS S; GEORGAKIS G; BADOURAKI M; SOULTANIDES C
      CONSERVATIVE TREATMENT OF HEMANGIOMAS IN INFANCY AND CHILDHOOD WITH INTERFERON-ALPHA 2A

      Pediatric surgery international
    66. PALMERI S; MELI M; DANOVA M; BERNARDO G; LEONARDI V; DASTOLI G; RAUSA L; RUSSO A; FILIPELLI G; PALMIERI G; RUSSO A; SCARPATI MD; LORUSSO V; DILAURO L; COLUCCI G; BRUNI G; PIAZZI M; GEBBIA N; SPADA S
      5-FLUOROURACIL PLUS INTERFERON ALPHA-2A COMPARED TO 5-FLUOROURACIL ALONE IN THE TREATMENT OF ADVANCED COLON-CARCINOMA - A MULTICENTRIC RANDOMIZED STUDY

      Journal of cancer research and clinical oncology
    67. WOLLINA U
      COMPLETE RESPONSE OF A PRIMARY CUTANEOUS T-CELL-RICH B-CELL LYMPHOMA TREATED WITH INTERFERON ALPHA-2A

      Journal of cancer research and clinical oncology
    68. Purohit, A; Moreau, L; Dietemann, A; Seibert, R; Pauli, G; Wihlm, JM; Quoix, E
      Weekly systemic combination of cisplatin and interferon alpha 2a in diffuse malignant pleural mesothelioma

      LUNG CANCER
    69. KWASNIEWSKA A; CHARZEWSKA J; TUKENDORF A; SEMCZUK M
      DIETARY FACTORS IN WOMEN WITH DYSPLASIA COLLI UTERI ASSOCIATED WITH HUMAN-PAPILLOMAVIRUS INFECTION

      Nutrition and cancer
    70. URABE T; KANEKO S; MATSUSHITA E; UNOURA M; KOBAYASHI K
      CLINICAL PILOT-STUDY OF INTRAHEPATIC ARTERIAL CHEMOTHERAPY WITH METHOTREXATE, 5-FLUOROURACIL, CISPLATIN AND SUBCUTANEOUS INTERFERON-ALPHA-2B FOR PATIENTS WITH LOCALLY ADVANCED HEPATOCELLULAR-CARCINOMA

      Oncology
    71. BAFALOUKOS D; FOUNTZILAS G; SKARLOS D; PAVLIDIS N; BAKOYIANNIS C; KARVOUNIS N; KOSMIDIS P
      SUBCUTANEOUS LOW-DOSES OF INTERLEUKIN-2 AND RECOMBINANT INTERFERON-ALPHA WITH CARBOPLATIN AND VINBLASTINE IN PATIENTS WITH ADVANCED MELANOMA

      Oncology
    72. ELSTNER E; MULLER C; KOSHIZUKA K; WILLIAMSON EA; PARK D; ASOU H; SHINTAKU P; SAID JW; HEBER D; KOEFFLER HP
      LIGANDS FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA AND RETINOIC ACID RECEPTOR INHIBIT GROWTH AND INDUCE APOPTOSIS OF HUMAN BREAST-CANCER CELLS IN-VITRO AND IN BNX MICE

      Proceedings of the National Academy of Sciences of the United Statesof America
    73. PERRY CM; WILDE MI
      INTERFERON-ALPHA-2A - A REVIEW OF ITS USE IN CHRONIC HEPATITIS-C

      Biodrugs
    74. KIVISAKK P; ALM GV; TIAN WZ; MATUSEVICIUS D; FREDRIKSON S; LINK H
      NEUTRALIZING AND BINDING ANTI-INTERFERON-BETA-1B (IFN-BETA-1B) ANTIBODIES DURING IFN-BETA-1B TREATMENT OF MULTIPLE-SCLEROSIS

      Multiple sclerosis
    75. COOKSLEY WGE; MCIVOR C; WATSON K; SMITH B; JACKSON P; BROTODIHARDJO A; FARRELL GC; JONES DB; NGU M; MCCAUGHAN GW; OBRIEN E; KAVANAGH J; MORROW AW; DUDLEY F; CROMIE S; JENKINS P; HARLEY H; SHAW D; BATEY RG; CREWE E; BOWDEN S; LOCARNINI S; CUNNINGHAM A
      EFFICACY AND TOLERANCE OF A 6-MONTH TREATMENT COURSE OF DAILY INTERFERON-ALPHA-2A FOR CHRONIC HEPATITIS-C WITH CIRRHOSIS

      Journal of viral hepatitis
    76. HUSSAIN M; GILL DS; LIAO MJ
      BOTH VARIANT FORMS OF INTERFERON-ALPHA-4 GENE (IFNA4A AND IFNA4B) AREPRESENT IN THE HUMAN-POPULATION

      Journal of interferon & cytokine research
    77. WALPOLE ET; HERSEY P; THOMSON D; MCLEOD GRC
      RECOMBINANT INTERFERON-ALPHA-2A PLUS 5-FLUOROURACIL FOR THE TREATMENTOF METASTATIC MELANOMA

      Melanoma research
    78. CHENG AL; CHUANG SF; SU IJ
      FACTORS ASSOCIATED WITH THE THERAPEUTIC EFFICACY OF RETINOIC ACIDS ONMALIGNANT-LYMPHOMAS

      Journal of the Formosan Medical Association
    79. OBERG K; ALM G
      THE INCIDENCE AND CLINICAL-SIGNIFICANCE OF ANTIBODIES TO INTERFERON-AIN PATIENTS WITH SOLID TUMORS

      Biotherapy
    80. KHURI FR; KURIE JM; HONG WK
      CHEMOPREVENTION OF RESPIRATORY-TRACT CANCER

      Hematology/oncology clinics of North America
    81. MILLER VA; BENEDETTI FM; RIGAS JR; VERRET AL; PFISTER DG; STRAUS D; KRIS MG; CRISP M; HEYMAN R; LOEWEN GR; TRUGLIA JA; WARRELL RP
      INITIAL CLINICAL-TRIAL OF A SELECTIVE RETINOID-X RECEPTOR-LIGAND, LGD1069

      Journal of clinical oncology
    82. CARDAMAKIS E; RELAKIS K; GINOPOULOS P; KORANTZIS A; METALINOS K; STATHOPOULOS E; PAPATHANASIOU Z; MICHOPOULOS J; MANTOUVALOS H; KOTOULAS IG; TZINGOUNIS V
      TREATMENT OF PENILE INTRAEPITHELIAL NEOPLASIA (PIN) WITH INTERFERON ALPHA-2A, CO2-LASER (VAPORIZATION) AND 5-FLUOROURACIL 5-PERCENT (5-FU)

      European journal of gynaecological oncology
    83. PERERA F; FISHER B; KOCHA W; PLEWES E; TAYLOR M; VINCENT M
      A PHASE-I PILOT-STUDY OF PELVIC RADIATION AND ALPHA-2A INTERFERON IN PATIENTS WITH LOCALLY ADVANCED OR RECURRENT RECTAL-CANCER

      International journal of radiation oncology, biology, physics
    84. REGAZZI MB; IACONA I; GERVASUTTI C; LAZZARINO M; TOMA S
      CLINICAL PHARMACOKINETICS OF TRETINOIN

      Clinical pharmacokinetics
    85. LEE WM
      THERAPY OF HEPATITIS-C - INTERFERON ALFA-2A TRIALS

      Hepatology
    86. NAGLER A; NAGLER R; ACKERSTEIN A; LEVI S; MARMARY Y
      MAJOR SALIVARY-GLAND DYSFUNCTION IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES RECEIVING INTERLEUKIN-2-BASED IMMUNOTHERAPY POST-AUTOLOGOUS BLOOD STEM-CELL TRANSPLANTATION (ABSCT)

      Bone marrow transplantation
    87. DIPPOLD W; BERNHARD H; ZUMBUSCHENFELDE KHM
      CHEMOTHERAPY IN ADVANCED PANCREATIC-CANCER

      International journal of pancreatology
    88. IMAI Y; KAWATA S; TAMURA S; ITO N; SEKI K; NISHIUCHI M; SHINJI Y; KIRIYAMA K; HIMENO S; MINAMI Y; KASHIHARA T; KAWAKAMI F; MAEDA H; YABUUCHI I; NISHIOKA M; SHIRAI Y; FUKUDA K; KISO S; ITO T; IGURA T; DOI Y; MATSUZAWA Y
      RECOMBINANT INTERFERON-ALPHA-2A FOR TREATMENT OF CHRONIC HEPATITIS-C - RESULTS OF A MULTICENTER RANDOMIZED CONTROLLED DOSE STUDY

      Liver
    89. DEB G; JENKNER A; DESIO L; BOLDRINI R; BOSMAN C; STANDOLI N; DONFRANCESCO A
      SPINDLE-CELL (KAPOSIFORM) HEMANGIOENDOTHELIOMA WITH KASABACH-MERRITT SYNDROME IN AN INFANT - SUCCESSFUL TREATMENT WITH ALPHA-2A INTERFERON

      Medical and pediatric oncology
    90. NORDOY I; KRARUP HB; BELL H; CHRISTENSEN PB; ELGJO K; VONDERLIPPE B; DEMUCKADELL OS; MAELAND A; RINGLARSEN H; SAMDAL HH; SIMMONDS P; SKAUG K; TAGEJENSEN U; SCHRUMPF E
      INTERFERON-ALPHA-2B THERAPY IN LOW-ACTIVITY HEPATITIS-C - A PILOT-STUDY

      Scandinavian journal of gastroenterology
    91. CHRISTEFF N; GHARAKHANIAN S; THOBIE N; WIRBEL E; DALLE MT; COSTAGLIOLA D; NUNEZ EA; ROZENBAUM W
      EFFECT OF INTERFERON-ALPHA ON HIGH SERUM ANDROGEN CONCENTRATIONS IN HIV-POSITIVE MEN WITH KAPOSIS-SARCOMA

      Journal of Clinical Pathology
    92. VANDERLEEDE BM; VANDENBRINK CE; PIJNAPPEL WWM; SONNEVELD E; VANDERSAAG PT; VANDERBURG B
      AUTOINDUCTION OF RETINOIC ACID METABOLISM TO POLAR DERIVATIVES WITH DECREASED BIOLOGICAL-ACTIVITY IN RETINOIC ACID-SENSITIVE, BUT NOT IN RETINOIC ACID-RESISTANT HUMAN BREAST-CANCER CELLS

      The Journal of biological chemistry
    93. KAWA S; NIKAIDO T; AOKI Y; ZHAI YL; KUMAGAYA T; FURIHATA K; FUJII S; KIYOSAWA K
      AROTINOID MOFAROTENE (RO40-8757) UP-REGULATES P21 AND P27 DURING GROWTH-INHIBITION OF PANCREATIC-CANCER CELL-LINES

      International journal of cancer
    94. LIPPMAN SM; LOTAN R; SCHLEUNIGER U
      RETINOID-INTERFERON THERAPY OF SOLID TUMORS

      International journal of cancer
    95. FORMELLI F; CAVADINI E; MASCHERONI L; BELLI F; CASCINELLI N
      PHARMACOKINETICS AND EFFECTS ON PLASMA RETINOL CONCENTRATIONS OF 13-CIS-RETINOIC ACID IN MELANOMA PATIENTS

      British Journal of Cancer
    96. DARNOWSKI JW; DAVOL PA; GOULETTE FA
      HUMAN RECOMBINANT INTERFERON ALPHA-2A PLUS 3'-AZIDO-3'-DEOXYTHYMIDINE- SYNERGISTIC GROWTH-INHIBITION WITH EVIDENCE OF IMPAIRED DNA-REPAIR IN HUMAN COLON ADENOCARCINOMA CELLS

      Biochemical pharmacology
    97. EUVRARD S; KANITAKIS J; THIVOLET J; CLAUDY A
      RETINOIDS FOR THE MANAGEMENT OF DERMATOLOGICAL COMPLICATIONS OF ORGAN-TRANSPLANTATION

      Biodrugs
    98. DMITROVSKY E
      N-(4-HYDROXYPHENYL)RETINAMIDE ACTIVATION OF A DISTINCT PATHWAY SIGNALING APOPTOSIS

      Journal of the National Cancer Institute
    99. LANVERS C; HEMPEL G; BLASCHKE G; BOOS J
      SIMULTANEOUS DETERMINATION OF ALL-TRANS-RETINOIC, 13-CIS-RETINOIC AND9-CIS-RETINOIC ACID, THEIR 4-OXO METABOLITES AND ALL-TRANS-RETINOL INHUMAN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY

      Journal of chromatography B. Biomedical applications
    100. QUAN WDY; CASAL R
      WEEKLY 5-FLUOROURACIL AND INTERFERON-ALFA-2B IN METASTATIC CANCER

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/01/21 alle ore 18:21:11